Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(20):1513-1515; doi:10.1093/jnci/93.20.1513
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hansen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hansen, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 20, 1513-1515, October 17, 2001
© 2001 Oxford University Press


EDITORIAL

Light at Night, Shiftwork, and Breast Cancer Risk

Johnni Hansen

Correspondence to: Johnni Hansen, Ph.D., Danish Cancer Society, Institute of Cancer Epidemiology, Strandboulevarden 49, DK-2100 Copenhagen, Denmark (e-mail: johnni@cancer.dk).

Breast cancer is the most commonly diagnosed female noncutaneous cancer in the United States and in Europe. The etiology of breast cancer is primarily unknown, with an estimated one quarter of all breast cancers possibly due to heritable factors (1) and only a minor proportion possibly due to already established environmental risk factors, such as early age at menarche, older age at first pregnancy, and delayed menopause (2). Because the incidence of breast cancer in many countries is increasing, for unclear reasons, it is not surprising that society is demanding explanations for the increased incidence of the disease and that researchers are searching for new causes. One avenue of research has been the so-called "man-made endocrine disrupting chemicals," such as 2-(chlorphenyl)-2-(4-chlorphenyl)-1,1,1-trichlorethan (DDT), polychlorinated biphenyls, or nonyl phenols (3). So far, however, . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
A. H. Wu, R. Wang, W.-P. Koh, F. Z. Stanczyk, H.-P. Lee, and M. C. Yu
Sleep duration, melatonin and breast cancer among Chinese women in Singapore
Carcinogenesis, June 1, 2008; 29(6): 1244 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
S. Gery and H. P. Koeffler
The Role of Circadian Regulation in Cancer
Cold Spring Harb Symp Quant Biol, January 1, 2007; 72(0): 459 - 464.
[Abstract] [PDF]


Home page
Am J EpidemiolHome page
T. C. Erren
RE: "OCCUPATIONAL MAGNETIC FIELDS AND FEMALE BREAST CANCER: A CASE-CONTROL STUDY USING SWEDISH POPULATION REGISTERS AND NEW EXPOSURE DATA"
Am. J. Epidemiol., August 15, 2005; 162(4): 392 - 393.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
S.-T. Chen, K.-B. Choo, M.-F. Hou, K.-T. Yeh, S.-J. Kuo, and J.-G. Chang
Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers
Carcinogenesis, July 1, 2005; 26(7): 1241 - 1246.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Kayumov, R. F. Casper, R. J. Hawa, B. Perelman, S. A. Chung, S. Sokalsky, and C. M. Shapiro
Blocking Low-Wavelength Light Prevents Nocturnal Melatonin Suppression with No Adverse Effect on Performance during Simulated Shift Work
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2755 - 2761.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. Filipski, P. F. Innominato, M. Wu, X.-M. Li, S. Iacobelli, L.-J. Xian, and F. Levi
Effects of Light and Food Schedules on Liver and Tumor Molecular Clocks in Mice
J Natl Cancer Inst, April 6, 2005; 97(7): 507 - 517.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Filipski, F. Delaunay, V. M. King, M.-W. Wu, B. Claustrat, A. Grechez-Cassiau, C. Guettier, M. H. Hastings, and L. Francis
Effects of Chronic Jet Lag on Tumor Progression in Mice
Cancer Res., November 1, 2004; 64(21): 7879 - 7885.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. C. Travis, D. S. Allen, I. S. Fentiman, and T. J. Key
Melatonin and Breast Cancer: A Prospective Study
J Natl Cancer Inst, March 17, 2004; 96(6): 475 - 482.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K.-A. Phillips, R. L. Milne, M. L. Friedlander, M. A. Jenkins, M. R.E. McCredie, G. G. Giles, and J. L. Hopper
Prognosis of Premenopausal Breast Cancer and Childbirth Prior to Diagnosis
J. Clin. Oncol., February 15, 2004; 22(4): 699 - 705.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
I. H. Kavakli and A. Sancar
Circadian Photoreception in Humans and Mice
Mol. Interv., December 1, 2002; 2(8): 484 - 492.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. Filipski, V. M. King, X. Li, T. G. Granda, M.-C. Mormont, X. Liu, B. Claustrat, M. H. Hastings, and F. Levi
Host Circadian Clock as a Control Point in Tumor Progression
J Natl Cancer Inst, May 1, 2002; 94(9): 690 - 697.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
N. Kerenyi
Re: Night Shift Work, Light at Night, and Risk of Breast Cancer
J Natl Cancer Inst, April 3, 2002; 94(7): 531 - 532.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. Hansen
RESPONSE: Re: Night Shift Work, Light at Night, and Risk of Breast Cancer
J Natl Cancer Inst, April 3, 2002; 94(7): 533 - 534.
[Full Text] [PDF]